FIELD: medicine.
SUBSTANCE: probiotic strain Enterococcus faecium L3 with a titre of (4-6)×108 CFU/ml is administered per os in the liquid form in a dose of 5.0 ml two times a day at mealtimes for three months.
EFFECT: method enables reducing an incidence of acute respiratory viral infections in the infants by improving the trophological status.
3 tbl, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR PREDICTION OF SUCCESS RATE OF INFECTIOUS COMPLICATION PREVENTION IN PREMATURE INFANTS | 2012 |
|
RU2502995C1 |
| METHOD OF TREATING LOW-BODY-WEIGHT PREMATURE NEWBORNS | 2012 |
|
RU2514346C1 |
| METHOD FOR TREATMENT OF FUNCTIONAL DISEASES OF GASTROINTESTINAL TRACT IN CHILDREN | 2021 |
|
RU2766765C1 |
| METHOD FOR PREDICTION OF NONSPECIFIC COMPLICATIONS OF ACUTE INTESTINAL INFECTIONS WITH HEMORRHAGIC COLITIS SYNDROME IN CHILDREN | 2019 |
|
RU2704132C1 |
| METHOD FOR TREATMENT OF PROLONGED COURSE OF INTESTINAL INFECTION OF CAMPYLOBACTER ETIOLOGY IN YOUNG CHILDREN | 2022 |
|
RU2788397C1 |
| METHOD FOR COMPLEX THERAPY OF PEDIATRIC PATIENTS WITH VIRAL INFECTION USING PROBIOTIC FOOD PRODUCTS | 2021 |
|
RU2793833C1 |
| METHOD OF PREVENTING INFLUENZA AND ACUTE RESPIRATORY INFECTIONS IN CHILDREN SUFFERING BRONCHIAL ASTHMA | 2011 |
|
RU2456020C1 |
| LIVE VACCINE BASED ON ENTEROCOCCUS FAECIUM L3 PROBIOTIC STRAIN FOR PREVENTION OF INFECTION CAUSED BY STREPTOCOCCUS PNEUMONIE | 2018 |
|
RU2701733C1 |
| APPLICATION OF THERAPEUTICALLY EFFECTIVE QUANTITY OF Bb-12 AND LGG FOR PRODUCTION OF CURING OR RESPIRATORY INFECTION AND ACUTE MEDIA OTITIS PREVENTING MEDIUM FOR BABIES | 2005 |
|
RU2332224C1 |
| METHOD FOR STRENGTHENING FREQUENTLY FALLING ILL CHILDREN HEALTH | 2005 |
|
RU2297822C2 |
